# Adjunct Immunotherapy With Immunoxel in Patients With TB and TB/HIV

> **NCT01061593** · PHASE3 · COMPLETED · sponsor: **Lisichansk Regional Tuberculosis Dispensary** · enrollment: 269 (actual)

## Conditions studied

- Tuberculosis
- HIV

## Interventions

- **DIETARY_SUPPLEMENT:** Immunoxel
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01061593
- **Lead sponsor:** Lisichansk Regional Tuberculosis Dispensary
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2015-03
- **Final completion:** 2015-04
- **Target enrollment:** 269 (ACTUAL)
- **Last updated:** 2015-05-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01061593

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01061593, "Adjunct Immunotherapy With Immunoxel in Patients With TB and TB/HIV". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01061593. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*